Skip to content

Effects of Intramuscular Electrical Stimulation on Upper Trapezius Trigger Points Treatment

Effects of Single Session Intramuscular Electrical Stimulation through Dry Needling on Pain and Dysfunction Following Trigger Points in Upper Trapezius Muscle

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017061634567N1
Enrollment
30
Registered
2017-08-05
Start date
2017-09-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigger Points in Upper Trapezius Muscle.

Interventions

Intervention group: The intervention in this group is intramuscular electrical stimulation. The patient is in prone, while the hands are placed next to the body and the head is in the midline. For a p
Treatment - Other

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1. Active trigger points with specific bundle in upper trapezius muscle 2. The pain associated with the trigger point of the upper trapezius muscle be higher than 3 based on the VAS scale, which is considered as moderate pain. 3. Age 18-40 4. Do not give injections or other treatments for trigger points within a month before the study. 5. No history of muscle diseases such as fibromyalgia and myopathy. 6. No malignancy or patients susceptible to infection. 7. Not having central and peripheral neurological disorders. 8. Not having radical pain and history of neck surgery. 9. have no previous history of bad response to acupuncture or dry needling. 10. No pregnancy 11. Do not use anticoagulants. 12. No significant fears from the dry needling. 13. Not having vascular disease. 14. Not having diabetes. 15. Not having a history of migraine. exclusion criteria: 1. Withdrawal of cooperation by the patient. 2. Discomfort and intolerance method applied to the patient. 3. Incidence of abnormal reactions during dry needling and treatment.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: before application, exactly after treatment and one week after treatment. Method of measurement: by visual analog scale.;Pain Pressure Threshold. Timepoint: before application, exactly after treatment and one week after treatment. Method of measurement: by algometer.;Range of motion. Timepoint: before application, exactly after treatment and one week after treatment. Method of measurement: by goniometer.

Secondary

MeasureTime frame
Disability. Timepoint: before application and week after treatment. Method of measurement: by Neck Disability Index.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactmonavar hadizadeh

Tehran University of Medical Sciences

hadizadeh-m@razi.tums.ac.ir+98 21 7753 3939

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026